Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1440]
News [2191]
Articles [39]
Editorials [5]
Conferences [149]
elearning [0]
Long term outcome of enfortumab vedotin + pembrolizumab in first line locally...
Dr Terence Friedlander - UCSF, San Francisco, USA
Long term outcome of enfortumab vedotin + pembrolizumab in first line locally advanced or metastatic urothelial carcinoma ( Dr Terence Friedlander - UCSF, San Francisco, USA )
4 Jun 2021
ASCO 2021: Renal cancer roundup
Dr Bradley McGregor - Dana-Farber Cancer Institute, Boston, USA
ASCO 2021: Renal cancer roundup ( Dr Bradley McGregor - Dana-Farber Cancer Institute, Boston, USA )
4 Jun 2021
RELATIVITY-047: Relatlimab (RELA) plus nivolumab (NIVO) versus NIVO in first...
Dr Evan Jacob Lipson - Johns Hopkins Sidney Kimmel Comprehensive Cancer Center...
RELATIVITY-047: Relatlimab (RELA) plus nivolumab (NIVO) versus NIVO in first-line advanced melanoma ( Dr Evan Jacob Lipson - Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )
4 Jun 2021
European Cancer Organisation - Time to Act
Dr Mirjam Crul - Amsterdam University Medical Center, Amsterdam, Netherlands
European Cancer Organisation - Time to Act ( Dr Mirjam Crul - Amsterdam University Medical Center, Amsterdam, Netherlands )
19 May 2021
Language and understanding: The complexity of insight in cancer care
Dr Tianna Martin - Beaumont Hospital, Dublin, Ireland
Language and understanding: The complexity of insight in cancer care ( Dr Tianna Martin - Beaumont Hospital, Dublin, Ireland )
22 Apr 2021
CONVERT trial: Patterns of relapse following thoracic radiotherapy in patients...
Dr Robin Portner - The Christie NHS Foundation Trust, Manchester, UK
CONVERT trial: Patterns of relapse following thoracic radiotherapy in patients with limited-stage SCLC ( Dr Robin Portner - The Christie NHS Foundation Trust, Manchester, UK )
19 Apr 2021
Randomised phase III study of copanlisib plus rituximab vs rituximab/placebo in...
Dr Matthew Matasar - Memorial Sloan Kettering Cancer Center, NYC, US
Randomised phase III study of copanlisib plus rituximab vs rituximab/placebo in relapsed indolent non-Hodgkin lymphoma ( Dr Matthew Matasar - Memorial Sloan Kettering Cancer Center, NYC, US )
16 Apr 2021
Which factors impact viewer satisfaction in educational videos?
Danny Burke and Dr Eva Hofstädter-Thalmann
Which factors impact viewer satisfaction in educational videos? ( Danny Burke and Dr Eva Hofstädter-Thalmann )
15 Apr 2021
The Conquering Cancer Campaign
Prof Karen Canfell - University of Sydney, Sydney, Australia
The Conquering Cancer Campaign ( Prof Karen Canfell - University of Sydney, Sydney, Australia )
26 Mar 2021
ecancer special issue on medical education in Africa
Prof Cristina Stefan - SingHealth Duke-NUS Global Health Institute, Singapore
ecancer special issue on medical education in Africa ( Prof Cristina Stefan - SingHealth Duke-NUS Global Health Institute, Singapore )
23 Mar 2021
OncoAlert and ecancer weekly roundup for March 01 - 06, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for March 01 - 06, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
8 Mar 2021
UICC Breast Cancer Programme: update and opportunities
Sabrina Zucchello - Grants Manager, UICC
UICC Breast Cancer Programme: update and opportunities ( Sabrina Zucchello - Grants Manager, UICC )
5 Mar 2021

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation